Recent Cancer Treatment Research for January 2025
2022-2026 Costa Rica Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportuniti
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Costa Rica
| Advanced Cervical Cancer - Pipeline Insight, 2021
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
| Advanced Gastric Carcinoma - Pipeline Insight, 2021
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Cancer Immunotherapy Market Forecasts to 2028 – Global Analysis By Application (Blood Cancers, Ovarian Cancer, Pancreatic Cancer, Liver Cancer), End User (Hospitals & Clinics, Ambulatory Surgical Centres) and By Geography
Topics: Drug Development, Cancer Treatment, Hospitals & Clinics, Prescription Drugs, Drug Discovery, Oncology/Hematology, Obstetrics/Gynecology
Regions: Global
| 2022-2026 Africa Clinical Chemistry and Immunodiagnostic Analyzers and Reagents in 6 Countries - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Tech
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Africa
| 2022-2026 Chile Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities fo
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Chile
| 2022-2026 New Zealand Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, V
Topics: Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: New Zealand
| 2022-2026 US Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: United States
| 2022-2026 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Vol
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Venezuela
| 2022-2026 World Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests in 90 Countries High-Growth Opportunities for Suppliers, Competitive Shares and Growth Str
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Global
| Global Antibody Drug Conjugates (ADC); By Type (Cleavable Linker and Non-cleavable Linker), By Application (Blood Cancer (Leukemia, Multiple Myeloma, Lymphoma, Breast Cancer, Urothelial Cancer & Bladder Cancer and Others), By End Users (Research Institute
Topics: Antibody Technologies, Cancer Treatment, Hospitals & Clinics, Women's Health, Oncology/Hematology
Regions: Africa, Asia, Europe, North America, Oceania, South America, Global
| 2022-2026 Emerging Cancer Diagnostic Tests, Country Market Shares, Strategic Profiles of Leading Reagent and Instrument Suppliers
Topics: Cancer Treatment, Hematology & Oncology
| 2022 Cancer Diagnostic Instrumentation, and Strategic Profiles of Leading Suppliers
Topics: Instrumentation & Equipment, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
| 2022-2026 Asia-Pacific Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests in 18 Countries High-Growth Opportunities for Suppliers, Competitive Shares and Gro
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Asia, Oceania
| 2022-2026 Australia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Vol
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Australia
| 2022-2026 Austria Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volum
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Austria
| 2022-2026 Belarus Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volum
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Belarus
| 2022-2026 Bolivia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volum
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Bolivia
| 2022-2026 Brazil Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Brazil
| 2022-2026 Bulgaria Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volu
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Bulgaria
| 2022-2026 Russia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Russia
| 2022-2026 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volum
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Ukraine
| 2022-2026 Ukraine Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Ukraine
| Laryngeal Cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Primary Gastric Lymphoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Synchronous Endometrial and Ovarian Cancer (SEOC) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
| Undifferentiated Pleomorphic Sarcoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Vulvar Squamous Cell Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology, Obstetrics/Gynecology
| Metastatic Cutaneous Squamous Cell Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Lung Adenocarcinoma - Epidemiology Forecast - 2032
Topics: Cancer Treatment, Drug Discovery
| South and Central America Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infecti
Topics: Antibody Technologies, Cancer Treatment, Autoimmune, COVID-19/Coronavirus, Hospitals & Clinics, Infectious Diseases
Regions: Central America
| 2022-2029 Global Cancer Biomarkers Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)
Topics: Biomarkers, Cancer Treatment, Oncology/Hematology
Regions: Global
| Middle East and Africa Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious
Topics: Antibody Technologies, Cancer Treatment, Autoimmune, COVID-19/Coronavirus, Hospitals & Clinics, Infectious Diseases
Regions: Africa, Middle East
| Rat Model Market Size By Rat Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application (Research & Development, {Infectious Disease, Immunological Disease, Cancer, Car
Topics: Stem Cell, DNA Sequencing, Diabetes, Cancer Treatment, Veterinary Health
| Cervical Cancer Diagnostics Global Market Report 2022
Including: 1) By Diagnostic Test: Pap Smear Test; HPV Test; Colposcopy; Biopsy and Endocervical Curettage; Other Diagnostic Tests
2) By End User: Hospitals; Specialty Clinics; Cancer and Radiation The
Topics: Adults (18-55), Cancer Treatment, Hospitals & Clinics, Hematology & Oncology, Gynecological Devices, Women's Health, Obstetrics/Gynecology
Regions: Global
| 2022-2026 Albania Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Albania
| 2022-2026 Finland Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volum
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Finland
| 2022-2026 Netherlands Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunit
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Netherlands
| Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Breast Cancer, Urothelial/Bladder Cancer), By Technology (Cleavable, Non-cleavable Linker, Linkerless), And Segment Forecasts, 2022 - 2030
Topics: Antibody Technologies, Cancer Treatment, Oncology/Hematology
| 2022-2026 Iceland Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volum
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Iceland
| 2022-2026 Iceland Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Iceland
| Pain Management Devices Market by Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Neuropathy, Cancer, Facial, MSK, Migraine), Mode of Purchase (OTC, Prescription-based) & Region (NA, Europe, APAC) - Global Forecasts to 2026
Topics: Pain, Cancer Treatment, Infusion Products, Over-the-Counter Drugs, Prescription Drugs, CNS/Neurology, Oncology/Hematology
Regions: Asia, Europe, Global
| Middle East and Turkey Chronic Liver Disease (CLD) Therapeutics Market, by Disease Type (Hepatitis, Alcohol Induced Liver Disease, Liver Cancer, Fatty Liver Disease, and Others), by Drug Class (Chemotherapy Drugs, Targeted therapy, Vaccines, Immunoglobuli
Topics: Antibody Technologies, Hepatitis, Cancer Treatment, Hospitals & Clinics, Vaccines, Drug Discovery, Clinical Nutrition
Regions: Egypt, Turkey, Israel, Saudi Arabia, United Arab Emirates, Middle East
| 2022-2026 Israel Cancer Diagnostics Market Segmentation Analysis and Database: Supplier Strategies, Emerging Tumor Markers, Volume and Sales Forecasts, Technology and Instrumentation Review
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Israel
| 2022-2026 Israel Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Israel
| 2022 Europe Cancer Diagnostics Market Shares in France, Germany, Italy, Spain, UK - Competitive Analysis of Leading and Emerging Market Players
Topics: Cancer Treatment, Hematology & Oncology
Regions: France, Germany, Italy, Spain, United Kingdom, Europe
| 2022-2026 Australia Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunitie
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Australia
| 2022-2026 Bolivia Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Bolivia
| South America Cervical Cancer Diagnostic Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider (Diagnostics and Research Labor
Topics: Cancer Treatment, COVID-19/Coronavirus, Hematology & Oncology, Microbiology & Virology, Gynecological Devices, Obstetrics/Gynecology
Regions: South America
| Hormone Sensitive Advanced Prostate Cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology, Men's Health
|
Prev | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
